3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Glucagen: new trials by email Literature Review of Glucagen trials Research Report on Glucagen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| In Vivo Assessment of Cellular Metabolism in Humans Somatostatin, Glucagon - Normal Cellular Metabolism | Phase 1 | Completed | K. Sreekumaran Nair | 17 | 2016-07-01 | 2022-08-03 |
| Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers Glucagen, Mayne Glucagon - Hypoglycemia | Phase 1 | Completed | Hospira, now a wholly owned subsidiary of Pfizer | 28 | 2007-08-01 | 2017-03-20 |
| A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002) MK-0893 10 mg, MK-0893 40 mg, MK-0893 200 mg - Type 2 Diabetes Mellitus | Phase 1 | Completed | Merck Sharp & Dohme LLC | 18 | 2005-07-01 | 2015-08-19 |
Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Hypoglycemia (1) · Metabolic Diseases (1)
Hospira, now a wholly owned subsidiary of Pfizer (1) · K. Sreekumaran Nair (1) · Merck Sharp & Dohme LLC (1)
United Kingdom (1) · United States (1)
K Sreekumaran Nair (1) · Stuart Mair (1)
2005 (1), U24DK100469 (1)